BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
11 hedge funds and large institutions have $8.25M invested in BioAmber Inc. in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
8% less funds holding
Funds holding: 12 → 11 (-1)
34% less capital invested
Capital invested by funds: $12.5M → $8.25M (-$4.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$24.4K |
| 2 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
+$22.9K |
| 3 |
Barclays
London,
United Kingdom
|
+$2.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$7.83K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.01K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WRF
1
Waddell & Reed Financial
Overland Park,
Kansas
| $4.58M | – | – | – |
|
|
ACPU
2
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $1.58M | – | – | – |
|
|
PRCM
3
Pine River Capital Management
Minnetonka,
Minnesota
| $877K | – | – | – |
|
|
MCM
4
Moore Capital Management
New York
| $403K | – | – | – |
|
|
SFM
5
Soros Fund Management
New York
| $307K | – | – | – |
|
|
LCS
6
Levin Capital Strategies
New York
| $289K | +$24.4K | +12,150 | +7% |
|
|
SCM
7
Saba Capital Management
New York
| $102K | -$7.83K | -3,900 | -6% |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $59K | -$6.01K | -2,994 | -8% |
|
|
PWAM
9
Park West Asset Management
San Francisco,
California
| $25K | – | – | – |
|
|
PSC
10
Piper Sandler & Co
Minneapolis,
Minnesota
| $19K | +$22.9K | +11,426 | New |
|
|
11
Barclays
London,
United Kingdom
| $1K | +$2.52K | +1,253 | +588% |
|
BIOA.WS Hedge Fund Activity: Q4 2014 in Review
11 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q4 2014, worth a combined $8.25M — down 34% from $12.5M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIOA.WS positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $24.4K. The largest seller was Saba Capital Management, cutting an estimated $7.83K.
- 11 institutional investors held BioAmber Inc. (BIOA.WS) as of Q4 2014, down from 12 in Q3 2014.
- Funds reported $8.25M of BioAmber Inc. stock for Q4 2014, down 34% quarter-over-quarter.
- 1 fund opened new BioAmber Inc. positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest BioAmber Inc. buyer in Q4 2014 was Levin Capital Strategies, an estimated $24.4K added.
- The largest BioAmber Inc. seller in Q4 2014 was Saba Capital Management, an estimated $7.83K sold.
Based on aggregated 13F filings for Q4 2014.